Rchr
J-GLOBAL ID:201601001208275062   Update date: Oct. 07, 2024

Itoh Ari

Itoh Ari
Affiliation and department:
Research field  (1): Immunology
Research theme for competitive and other funds  (5):
  • 2022 - 2025 急性骨髄性白血病治療に特化したCXCR4発現CD25標的キメラT細胞の解析
  • 2019 - 2022 Functional elucidation of transcription factor Bach2 in the development and maintenance of acute myeloid leukemia
  • 2017 - 2019 Elucidation of the acquisition mechanism of a long life in plasma cells
  • 2015 - 2017 A Bach2-Cebp gene regulatory network for the commitment of multipotent hematopoietic progenitors
  • 2015 - 2017 Regulation of lineage fate in hematopoietic stem cells by Bach2(Fostering Joint International Research)
Papers (46):
more...
MISC (18):
  • 稲垣弘文, 平田幸代, 清水孝子, 小林麻衣子, 伊藤亜里, 川田智之. Effect of IL-2 on the production of granzyme 3 in KHYG-1 cells. 日本薬学会年会要旨集(Web). 2023. 143rd
  • 稲垣弘文, 伊藤亜里, 平田幸代, 清水孝子, 小林麻衣子, 川田智之. KHYG-1細胞のグランザイム産生のFlow Cytometryによる解析. 日本生化学会大会(Web). 2023. 96th
  • Ari Itoh-Nakadai, Yoriko Saito, Mariko Murasawa-Tomizawa, Hiroshi Kajita, Takehisa Matsumoto, Masashi Matsuda, Takashi Watanabe, Mikako Shirouzu, Osamu Ohara, Haruhiko Koseki, et al. CXCR4-Expressing Anti-CD25 CAR T-Cells Effectively Eliminate Human AML Cells In Vivo. Blood. 2020. 136. Supplement 1. 35-36
  • Hiroki Kato, Ari Itoh-Nakadai, Mitsuyo Matsumoto, Risa Ebina-Shibuya, Yuki Sato, Masahiro Kobayashi, Akihiko Muto, Tohru Fujiwara, Hideo Harigae, Kazuhiko Igarashi. Transcription Factor Bach1 and Bach2 Operate Erythro-Myeloid Competitive Differentiation By Responding to Environmental Changes. BLOOD. 2016. 128. 22
  • Koichi Onodera, Tohru Fujiwara, Yasushi Onishi, Ari Itoh-Nakadai, Yoko Okitsu, Noriko Fukuhara, Kenichi Ishizawa, Ritsuko Shimizu, Masayuki Yamamoto, Hideo Harigae. GATA-2 Regulates Dendritic Cell Differentiation. BLOOD. 2015. 126. 23
more...
Lectures and oral presentations  (5):
  • Targeting poor prognosis acute myeloid leukemia with CD25-targeted chemokine receptor expressing CAR T cell therapy
    (2024)
  • Elucidating Tissue-Specific Metabolisms in Chimeric Antigen Receptor T-Cell Therapy
    (The 52nd Annual Meeting of the Japanese Society for Immunology 2024)
  • Targeting poor prognosis acute myeloid leukemia with CD25-targeted chemokine receptor expressing CAR T cell therapy
    (The 51st Annual Meeting of the Japanese Society for Immunology 2022)
  • Targeting poor prognosis leukemia with CD25-targeted chemokine receptor expressing CAR-T cell therapy
    (2022)
  • CXCR4-Expressing Anti-CD25 CAR T-Cells Effectively Eliminate Human AML Cells In Vivo
    (Blood 2020)
Professional career (1):
  • Ph.D (Tohoku University)
Awards (6):
  • 2021/12 - Best presentation award Targeting poor prognosis leukemia with CD25-targeted chemokine receptor expressing CAR Tcell therapy
  • 2019/12 - The Japanese Society for Immunology Best Presentation Award Creation of HLA class I and class II Tg NOD/SCID/Il2rgKO (NSG) mice for studying interaction between human immunity and leukemia
  • 2015/12 - The Japanese Society for Immunology Best Presentation Award Bach2 represses myeloid programs to promote lymphoid progenitor development under both the steady state and infection
  • 2015/10 - International Immunological Memory and Vaccine Forum (IIMVF) Travel award for Young Scientists -
  • 2015/03 - The Elkes foundation Keystone Symposia Future of science fund, National institution of allergy and infection diseases (NIAID) -
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page